2.05
price up icon1.49%   0.03
after-market Handel nachbörslich: 2.05
loading

Proqr Therapeutics N V Aktie (PRQR) Neueste Nachrichten

pulisher
08:38 AM

Will ProQR Therapeutics N.V. see short term momentumGold Moves & Fast Exit Strategy with Risk Control - Newser

08:38 AM
pulisher
06:37 AM

Candlestick signals on ProQR Therapeutics N.V. stock todayJuly 2025 Trends & Real-Time Market Sentiment Alerts - Newser

06:37 AM
pulisher
03:47 AM

Can ProQR Therapeutics N.V. rally from current levelsJuly 2025 Trade Ideas & Technical Entry and Exit Alerts - Newser

03:47 AM
pulisher
Aug 14, 2025

How institutional ownership impacts ProQR Therapeutics N.V. stockJuly 2025 EndofMonth & Safe Capital Growth Tips - Newser

Aug 14, 2025
pulisher
Aug 14, 2025

Real time alert setup for ProQR Therapeutics N.V. performanceJuly 2025 Volume & Free Community Consensus Stock Picks - Newser

Aug 14, 2025
pulisher
Aug 14, 2025

ProQR Therapeutics’ SWOT analysis: RNA editing pioneer’s stock faces clinical hurdles - Investing.com Australia

Aug 14, 2025
pulisher
Aug 14, 2025

Published on: 2025-08-14 04:18:44 - Newser

Aug 14, 2025
pulisher
Aug 13, 2025

Will breakout in ProQR Therapeutics N.V. lead to full recoveryJuly 2025 Market Mood & Scalable Portfolio Growth Ideas - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

How to build a dashboard for ProQR Therapeutics N.V. stock2025 Macro Impact & Fast Entry Momentum Alerts - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

How to track smart money flows in ProQR Therapeutics N.V.Bear Alert & Community Consensus Picks - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

ProQR Therapeutics (NASDAQ:PRQR) Earns Buy Rating from Chardan Capital - MarketBeat

Aug 13, 2025
pulisher
Aug 13, 2025

ProQR Therapeutics N.V. stock outlook for YEARIndex Update & AI Driven Stock Movement Reports - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Is ProQR Therapeutics N.V. stock entering bullish territory2025 Valuation Update & High Conviction Buy Zone Alerts - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

How high can ProQR Therapeutics N.V. stock goShare Buyback & Technical Entry and Exit Tips - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

How to track smart money flows in ProQR Therapeutics N.V. [2025 AllTime Highs]Free Community Verified Trade Signals - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Real time breakdown of ProQR Therapeutics N.V. stock performanceInsider Selling & Intraday High Probability Alerts - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Can ProQR Therapeutics N.V. recover in the next quarter2025 Price Action Summary & Long-Term Growth Plans - Newser

Aug 13, 2025
pulisher
Aug 12, 2025

How to forecast ProQR Therapeutics N.V. trends using time seriesMomentum Prediction Based on AI Backtesting - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

What to do if you’re stuck in ProQR Therapeutics N.V.Share Buyback & Real-Time Buy Signal Notifications - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Is ProQR Therapeutics N.V. stock a growth or value playMarket Performance Recap & Consistent Profit Alerts - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Buy Signal for ProQR Therapeutics N.V. Stock Key Technical Indicators to WatchFree Confirmed Setup With Expert Accuracy - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

ProQR Therapeutics (NASDAQ:PRQR) Stock Price Crosses Above 50-Day Moving AverageShould You Sell? - MarketBeat

Aug 12, 2025
pulisher
Aug 12, 2025

Using economic indicators to assess ProQR Therapeutics N.V. potentialFree Technical Entry Strategy for Beginners - Newser

Aug 12, 2025
pulisher
Aug 11, 2025

Volume spikes in ProQR Therapeutics N.V. stock – what they meanSummary of Trade Cycles in 5-Year Range - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

ProQR's Strategic Advancements and Clinical Prospects Drive Buy Rating with $12 Price Target - AInvest

Aug 11, 2025
pulisher
Aug 11, 2025

Statistical indicators supporting ProQR Therapeutics N.V.’s strengthFree Smart Allocation Stock Pick Insights - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

Live market analysis of ProQR Therapeutics N.V.Safe Momentum Strategy With Trend Analysis - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

Published on: 2025-08-10 23:41:36 - Newser

Aug 11, 2025
pulisher
Aug 10, 2025

Using Ichimoku Cloud for ProQR Therapeutics N.V. technicalsFree Price Action Based Buy Opportunity List - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Ranking ProQR Therapeutics N.V. among high performing stocks via toolsTechnical Safety Zone Pattern Recognition - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

ProQR Therapeutics (PRQR) to Release Earnings on Thursday - MarketBeat

Aug 10, 2025
pulisher
Aug 10, 2025

Is ProQR Therapeutics N.V. in Accumulation Phase NowMarket Momentum Signal Generator Shows Trends - beatles.ru

Aug 10, 2025
pulisher
Aug 09, 2025

ProQR Therapeutics Second Quarter 2025 Earnings: Misses Expectations - Yahoo Finance

Aug 09, 2025
pulisher
Aug 09, 2025

Analyzing ProQR Therapeutics N.V. with risk reward ratio chartsFree Swing Trading Entry Point Signals - Newser

Aug 09, 2025
pulisher
Aug 08, 2025

ProQR: Q2 Earnings Snapshot - Manistee News Advocate

Aug 08, 2025
pulisher
Aug 08, 2025

ProQR Therapeutics shares rise 3.17% intraday after reporting a Q2 loss of $13.8 million, missing Wall Street expectations. - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

ProQR Therapeutics Reports Q2 Earnings: $13.8mln Loss, $4.3mln Revenue - AInvest

Aug 08, 2025
$36.35
price down icon 0.41%
$86.92
price up icon 0.88%
$26.69
price up icon 0.91%
$127.80
price up icon 0.04%
$113.52
price up icon 0.73%
biotechnology ONC
$321.36
price up icon 3.77%
Kapitalisierung:     |  Volumen (24h):